FRED ALGER MANAGEMENT, LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 3520 NEW YORK, NY

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$97,508,578

+$96,129,692 QoQ

Shares Held

1,161,923

+3372.6% QoQ

Ownership

2.13%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

7 quarters on record

Voting authority Sole 95.25286959635018.ToString("F0")% Shared 0.ToString("F0")% None 4.747130403649812.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRED ALGER MANAGEMENT, LLC holds $649,233,872 across 51 Biotechnology names. DNTH ranks #2 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	3,342,493	$209,574,311
2	DNTH	Dianthus Therapeutics, Inc. /DE/ This page	1,161,923	$97,508,578
3	ASND	Ascendis Pharma A/S	304,896	$69,738,861
4	COGT	Cogent Biosciences, Inc.	1,239,700	$47,716,053
5	FBRX	Forte Biosciences, Inc.	1,273,965	$32,995,693
6	ACAD	Acadia Pharmaceuticals Inc	1,277,151	$28,429,380
7	ROIV	Roivant Sciences Ltd.	925,186	$25,627,652
8	INSM	INSMED Inc	125,766	$20,565,256

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$97,508,578	1,161,923	+3372.6%	Shares	Sole	2026-05-15
2025-12-31	$1,378,886	33,460	-26.1%	Shares	Sole	2026-02-17
2025-09-30	$1,782,712	45,304	+370.3%	Shares	Sole	2025-11-14
2024-09-30	$263,751	9,633	+52.5%	Shares	Sole	2024-11-14
2024-06-30	$163,483	6,317	-82.6%	Shares	Sole	2024-08-14
2024-03-31	$1,091,010	36,367	-11.0%	Shares	Sole	2024-05-15
2023-12-31	$424,746	40,841	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.